Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.9251
+0.0339 (3.80%)
At close: Oct 2, 2026, 4:00 PM EDT
0.9399
+0.0148 (1.60%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $87.97 million as of October 2, 2026. Its market cap has decreased by -33.96% in one year.
Market Cap
87.97M
Enterprise Value
54.55M
1-Year Change
-33.96%
Ranking
Category
Stock Price
$0.93
ChartMarket Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $87.97M, a decrease of -65.70%. That is a compound annual growth rate of -19.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 87.97M | -26.18% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 92.05M |
| Rallybio | 90.70M |
| Equillium | 89.41M |
| NeurAxis | 89.29M |
| ImmuCell | 88.55M |
| Nutriband | 88.49M |
| MediciNova | 87.61M |
| Conexeu Sciences | 87.44M |